NSE: SUPRIYA - Supriya Lifescience Limited

Yield per half year: +30.45%
Dividend yield: +0.24%
Sector: Healthcare

Share chart Supriya Lifescience Limited

en.porti.ru1000.001000.00800.00800.00600.00600.00400.00400.00200.00200.00Dec '23Dec '2320242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
Download SVG
Download PNG
Download CSV

About Supriya Lifescience Limited

Supriya Lifescience Ltd. занимается исследованиями, разработками, производством и продажей лекарственных препаратов и фармацевтических химикатов по всему миру. Он предлагает активные фармацевтические ингредиенты, такие как противоаллергические, противоастматические, противоотечные, обезболивающие/жаропонижающие/анестезирующие, антигипертензивные и противомалярийные препараты, а также витамины и производные ксантина. Компания была основана в 1987 году, ее штаб-квартира находится в Мумбаи, Индия.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN INE07RO01027
Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.239
Дивиденд ао 0.8
Сайт https://www.supriyalifescience.com
Цена ао 743.15
Change price per day: -1.18% (743.15)
Change price per week: +1.12% (726.25)
Change price per month: +15.06% (638.25)
Change price per 3 month: +4.38% (703.55)
Change price per half year: +30.45% (562.95)
Change price per year: +120.56% (332.95)
Change price per 3 year: +56.16% (470.25)
Change price per year to date: +3.28% (711.05)
All parameters

Underestimation

Title Value Grade
P/S 4.71 3
P/BV 3.29 5
P/E 22.55 6
EV/EBITDA 14.29 7
Total: 5.63

Efficiency

Title Value Grade
ROA, % 13.68 4
ROE, % 15.73 5
Total: 6

Dividends

Title Value Grade
Div yield, % 0.239 0.6
DSI 1 10
Total: 4.22

Debt

Title Value Grade
Debt/EBITDA 0.0299 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 83.02 9
Yield Ebitda, % 68.55 8
Yield EPS, % -48.49 0
Total: 5
More

ETFShare, %Profitability for 1 year, %Dividends, %
SPDR S&P Emerging Markets Small Cap ETF 0.02487 5.46 3.03583
Dimensional Emerging Markets Core Equity 2 ETF 0.00617 15.96 3.34087
WisdomTree India Earnings Fund 0.00145 5.23 1.65591
0.018.882.68



Head Job title Payment Year of birth
Dr. Shireesh Bhalchandra Ambhaikar Technical Head 892k
Ms. Shweta Shivdhari Singh Compliance Officer & Company Secretary 940k
Ms. Smita Satish Wagh Whole-time Director 15.66M 1958 (67 years)
Mr. Krishna Raghunathan Chief Financial Officer 3.34M
Dr. Sushanta Kumar Gouranga Mishra Chief Scientific Officer N/A
Dr. Prashant Baban Zate Head of Corporate Quality Assurance & Regulatory Affairs N/A
Dr. Satish Waman Wagh Founder, Executive Chairman & Whole Time Director 1955 (70 years)
Dr. Saloni Satish Wagh Managing Director 1990 (35 years)
Ms. Shivani Satish Wagh Joint Managing Director 1991 (34 years)
Mr. Balasaheb Gulabrao Sawant Whole Time Director 1964 (61 year)

Address: India, Mumbai, 207/208 Udyog Bhavan - open in Google maps, open in Yandex maps
Website: https://www.supriyalifescience.com